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Abstract
Background: Lung fibrosis is characterized by fibroblast proliferation and the deposition of collagens. Curcumin, a
polyphenol antioxidant from the spice tumeric, has been shown to effectively counteract fibroblast proliferation
and reducing inflammation and fibrotic progression in animal models of bleomycin-induced lung injury. However,
there is little mechanistic insight in the biological activity of curcumin. Here, we study the effects of curcumin on
the expression and activity of cathepsins which have been implicated in the development of fibrotic lung diseases.
Methods: We investigated the effects of curcumin administration to bleomycin stimulated C57BL/6 mice and
human fetal lung fibroblasts (HFL-1) on the expression of cathepsins K and L which have been implicated in matrix
degradation, TGF-b1 modulation, and apoptosis. Lung tissues were evaluated for their contents of cathepsins K and
L, collagen, and TGF-b1. HFL-1 cells were used to investigate the effects of curcumin and cathepsin inhibition on
cell proliferation, migration, apoptosis, and the expression of cathepsins K and L and TGF-b1.
Results: Collagen deposition in lungs was decreased by 17-28% after curcumin treatment which was accompanied
by increased expression levels of cathepsins L (25%-39%) and K (41%-76%) and a 30% decrease in TGF-b1
expression. Moreover, Tunel staining of lung tissue revealed a 33-41% increase in apoptotic cells after curcumin
treatment. These in vivo data correlated well with data obtained from the human fibroblast line, HFL-1. Here,
cathepsin K and L expression increased 190% and 240%, respectively, in the presence of curcumin and the
expression of TGF-b1 decreased by 34%. Furthermore, curcumin significantly decreased cell proliferation and
migration and increased the expression of surrogate markers of apoptosis. In contrast, these curcumin effects were
partly reversed by a potent cathepsin inhibitor.
Conclusion: This study demonstrates that curcumin increases the expression of cathepsins K and L in lung which
an effect on lung fibroblast cell behavior such as proliferation, migration and apoptosis rates and on the expression
of TGF-b1 in mouse lung and HFL-1 cells. These results suggest that cathepsin-inducing drugs such as curcumin
may be beneficial in the treatment of lung fibrosis.
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Background
Lung fibrosis is accompanied by fibroblast proliferation
and excessive extracellular matrix deposition primarily
in the form of collagens. This leads to a progressive loss
of lung function and ultimately death. Besides anti-
inflammatory drugs, there is presently no effective and
approved medication available in western countries.
However, curcumin, an antioxidant from the spice tur-
meric, is used as alternative medicine in India and
China for various inflammatory conditions and lung
related ailments and the NIH is presently funding sev-
eral clinical studies to evaluate the efficacy of curcumin
http://clinicaltrials.gov/ct2/results?term=curcumin.
Smith and coworkers, have recently demonstrated that
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tion of lung inflammation and collagen deposition in
bleomycin induced lung fibrosis in mice and relate these
effects to its anti-proliferative activity on fibroblasts and
interference in TGF-b1 mediated signaling pathways [1].
Other laboratories reported similar effects of curcumin
in related animal models of lung fibrosis [2-4]. However,
the exact mechanism of how curcumin exerts its lung
protective activity remains elusive.
Lung fibrosis is also accompanied by abnormal proteo-
lytic activity in lungs. Of particular interest are cysteine
cathepsins which are potent collagenases and elastases
and which have been implicated in caspase-independent
apoptosis pathways [5]. Cathepsins are widely expressed
in lung tissue [6,7]. It has been shown that cathepsin K
(CatK) deficiency exacerbates lung fibrosis in bleomy-
cin-induced lung injury [8] and that it interferes with
normal airway development [9]. On the other hand,
increased levels of CatK alleviate excessive extracellular
matrix deposition and consequently protect lungs from
bleomycin induced lung fibrosis [10]. Furthermore, over-
expression of CatK has been detected in human lung
fibrosis derived fibroblasts [8,11]. CatK is a very power-
f u lc o l l a g e n a s ea n de l a s t a s e[ 1 2 , 1 3 ] .W eh a v er e c e n t l y
demonstrated that CatK is also involved in the homeos-
tasis of TGF-b1 [9]. On the other hand, TGF-b1d o w n -
regulates CatK expression in fibroblasts and favors
fibrosis [11]. TGF-b1 also reduces the expression of
cathepsin L (CatL) in lung epithelial cell [14]. Accumu-
lating evidence suggests that elevated TGF-b1l e v e l sa r e
a consistent clinical feature of pulmonary fibrosis [15].
Upregulation of TGF-b1 resulted in fibroblast prolifera-
tion and differentiation as well as in abnormal collagen
deposition [1,16], whereas suppressed activity of TGF-b1
afforded a protection from fibrosis [17,18]. We have pre-
viously demonstrated that CatK expression suppresses
TGF-b1 expression in mouse lung [9]. To what extent
curcumin affects the level of cathepsin expression in
lung is unclear. The aim of this study is to investigate
the effect of curcumin on cathepsin expression in bleo-
mycin-treated mouse lungs and human lung fibroblasts,
and their involvement in fibrosis promoting cell beha-
viors such as proliferation, migration and apoptosis.
Materials and methods
Reagents and Antibodies
Bleomycin was obtained from Haizheng Pharmaceuticals
(Zhejiang, China). Curcumin, fetal calf serum (FBS),
Dulbecco’s Modified Eagle Medium (DMEM), and
mouse anti b-actin were purchased from Sigma (Saint
Louis, MO, USA), TRIzol Reagent for total RNA isola-
tion was from Invitrogen (Paisley, UK), One Step
SYBR
® PrimeScript
® RT-PCR Kit (DRR066A) for real
time RT-PCR from TaKaRa (Dalian, China). TdT-
mediated dUTP Nick End-labeling (Tunel) was from
Promega (Madison, WI, USA). Antibodies against Bax,
Bcl-2 and cleaved caspase-3 were obtained from Cell
Signaling Technology (Danvers, MA, USA) and goat
polyclonal anti-CatL from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), mouse anti TGF-b1 for immu-
nohistochemical staining from sigma, chicken anti TGF-
b1 for immunoblot analysis from R&D Systems (Min-
neapolis, MN, USA), and rabbit anti CatK from Protein-
Tech Group (Chicago, IL, USA). The peptidyl vinyl
sulfone inhibitor LHVS (Mu-Leu-hPh-VS-Ph) has been
synthesized as described in [19].
Bleomycin induced lung fibrosis
9-10 C57BL/6 mice per experimental group, age 8-14
weeks, were used in the fibrosis model. Mice were
housed in a barrier facility with specific pathogen-free
conditions and all experiments were performed using
protocols approved by the Beijing University of Chinese
Medicine Animal Care Unit. Briefly, mice were anesthe-
tized and the trachea was minimally exposed via a ven-
tral midline neck incision. Bleomycin sulfate (0.1 ml,
0.025 U/mouse, diluted in sterile saline) or equal
volumes of saline as control were slowly instilled intra-
tracheally as previously described [20]. The incision was
closed with surgical adhesive, and mice were allowed to
recover with free access to food and water. Mice were
treated (2
nd day after instillation) with curcumin (200
mg/kg) or saline alone daily in 0.5% carboxymethylcellu-
lose by gavage. Mice were euthanized at various time
points (at 1, 2, and 4 weeks) after bleomycin instillation.
Lung tissues were either flash frozen and then stored in
liquid nitrogen for further analysis or perfused and fixed
in 10% formalin for at least 24 h at room temperature
for immunohistochemical analysis.
Histochemical and immunohistochemical staining
5 μm sections were used for Hematoxylin and Eosin
(H&E) staining to evaluate the severity of lung inflam-
mation [21]. Masson Trichrome staining was performed
to assess the degree of fibrosis [22]. Microscopic images
were acquired with the 20× objective on a Leica micro-
scope (Leica Microsystems Inc., Wetzlar, Germany).
Immunohistochemical analysis of the lung tissue sam-
ples was performed following standard procedure.
Briefly, endogenous peroxidase activity was blocked by
immersion of deparaffinized sections in 3% H2O2 in
methanol for 30 min. Antigen retrieval was performed
by steaming slides in 0.01 M citrate buffer (pH 6.0) for
30 min. Slides were blocked with 1% bovine serum albu-
min for 30 min at room temperature and subsequently
incubated at 4°C overnight with antibodies against CatK
(1:100) and CatL (1:100), TGF-b1( 1 0μg/ml). To iden-
tify and exclude non-specific immunoglobulin binding
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species and at the same concentration as the experimen-
tal primary antibodies were used as controls. Subse-
quently, the slides were incubated with biotin
conjugated horse anti-mouse IgG (Pierce, Rockford, IL,
USA), goat anti-rabbit (Pierce) for 30 min at room tem-
perature. Then immunoreactions were visualized by
using avidin biotin conjugated horseradish peroxidase
and 3, 3’-diaminiobenzidine (DAB, Vector Labs, Burlin-
game, CA, USA) as substrate. Two tissue sections of
each specimen were assessed at a 40× original magnifi-
cation using a Leica microscope and evaluated with
Openlab software (PerkinElmer, Waltham, MA, USA).
Tunel assay
End-labeling of exposed 3’-OH ends of DNA fragments
was undertaken with the DeadEnd™ Fluorometric
Tunel System as described by the manufacturer. Briefly,
the tissue samples on slides were permeabilized with
proteinase K, then incubated with fluorescein 12-dUTP
and finally stained with propidium iodide. After staining,
whole lung was imaged using 5× magnification for
examination. Images were quantified using Openlab
software (PerkinElmer).
Real-time RT-PCR
mRNA levels were evaluated by using the TaKaRa One
Step real-time RT-PCR assay according to the manufac-
turer’s protocol. Total cellular RNA was extracted from
lungs using TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. The primer sequences were:
b-actin (forward, 5’-AGA GGG AAA TCG TGC GTG
AC-3’; reverse, 5’-CAA TAG TGA TGA CCT GGC
CGT-3’) and CatK (forward, 5’-ACT TGG GAG ACA
TGA CCA GTG A -3’; reverse, 5’-TCT TGA CTG GAG
TAA CGT ATC CTT TC-3’). To normalize the amount
of total RNA present in each reaction, b-actin cDNA
was employed as an internal control.
Human lung fibroblast (HFL-1) culture
HFL-1 cells were a gift from Dr. Clive Roberts, Univer-
sity of British Columbia (ATCC, CCL153). The cells
were cultured in DMEM containing 10% FBS, penicillin/
kanamycin. Cultures were maintained at 37°C in a
humidified atmosphere of 5% CO2. The medium was
changed every other day. Cells were treated with bleo-
mycin (0.1 mU/ml; dissolved in Phosphate buffered sal-
ine, PBS) and/or various concentrations of curcumin.
Drug treatments of cells and their controls were per-
formed in DMEM without FBS.
MTT assay
MTT [thiazolyl blue, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltertrazolium bromide, Sigma] was used to
determine cell viability and proliferation. At specified
time points, the culture medium was removed, and fibro-
blasts were incubated with 5 mg/ml MTT solution in an
incubator at 37°C for 3 h. After removing the medium,
200 μl of DMSO was added to each well of a 96-well
plate to solubilize the blue-colored tetrazolium and the
plates were then shaken for 5 min. Absorbance at 570
nm was recorded in a Spectramax Plus reader (Molecular
Devices, Sunnyvale, CA). Data were expressed in percen-
tage with the untreated samples set to 100%.
Wound healing assay
HFL-1 cells were evenly seeded into a 6-well plate. Cells
were starved for 24 h in serum free DMEM after reaching
at least 90% confluence. Three separate parallel scratch
wounds were made with a 200 μl pipette tip. After wash-
ing twice with PBS, 10% FBS in DMEM medium contain-
ing different concentrations of curcumin was added to the
cells. Images were taken under phase contrast inverted
microscopy at 0 and 24 h. The wound area was measured
using Openlab software and represented as percentage of
wound closure of the time zero wound area.
Transmigration assay
HFL-1 cells were cultured in DMEM containing 10%
FBS. When cells reached 70% confluence they were
starved in DMEM without FBS media for 24 h. Cells
were trypsinized and resuspended in serum free media.
Then 10
4 cells were seeded into the upper level of the
insert membrane (Transwell Permeable Supports, Corn-
ing, Lowell, MA) with different concentrations of curcu-
min. The bottom of the insert contained DMEM with
10% FBS. The invasion assay was carried out for 8 h in
the tissue culture incubator. After 8 h, inserts were
rinsed with PBS and stained with 0.5% crystal violet
solution in 25% methanol for 10 min. After washing the
inserts by dipping the inserts into distilled water, cells at
the top of the inserts were removed with a cotton swab.
The membrane was soaked in 1% SDS in PBS overnight.
On the second day, 200 μl of buffer were transferred to
a 96-well plate and the optical density (OD) was mea-
sured at a wavelength of 570 nm in a Spectramax Plus
reader. The percentage of migrated cells was calculated
based on the ODs of treated and untreated samples.
Immunoblot assay
Proteins in cell lysates were separated by SDS-PAGE
and then transferred to nitrocellulose membranes.
Membranes were incubated with appropriate primary
antibodies overnight at 4°C. The concentrations of pri-
mary antibodies were as follows: Bax (1:10000), BCL-2
(1:2000), cleaved caspase-3 (1:1000), b-actin (1:30000),
CatL (1:100), TGF-b1 (1:850), CatK (1:2000). Blots were
then washed with 0.05% Tween in PBS and incubated
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dase-conjugated secondary antibodies. Serial images of
the blots were captured and analyzed using the Chemi-
genius bioimaging system (Syngene, Cambridge, UK).
All values were normalized to expression of the corre-
sponding b-actin in the same membrane. Pixel densities
were corrected for background staining in the same
membrane.
Statistical analysis
Results are expressed as means ± SE for all mouse
related experiments. All other results are displayed as
means ± SD. All image analyses were performed by two
observers blinded to the group status. The significance
of differences of the mean values was calculated using
parametric ANOVA. A p value of less than 0.05 was
considered significant.
Results
Expressions of CatK and L in response to curcumin
treatment in lungs with bleomycin induced fibrosis and
HFL-1 cells
Cathepsins are involved in human lung development [6]
and are transiently upregulated in bleomycin induced
lung injury during the regeneration phase [23]. CatK,
one of most efficient collagenases [13], has been shown
to reduce collagen deposition in lungs of mice with
bleomycin induced lung fibrosis when overexpressed
[10]. Considering the known anti-fibrotic activity of cur-
cumin in lung [24], we evaluated the effect of curcumin
on the expression of CatK and L in bleomycin-induced
lung fibrosis. As shown in Figure 1A-C, CatK protein
expression in curcumin treated mice was increased by
63%, 76% and 41% at 7d, 14d and 28d, respectively and
that of CatL by 25%, 39% and 38% when compared to
bleomycin treated mice. Further, at 7d, 14d and 28d,
CatK mRNA levels (Figure 1D) in the curcumin treated
group also increased by 17%, 44% and 20%, respectively.
It should be noted that bleomycin treatment causes
maximal fibrosis already after one week.
Similar to the expression of CatK and L in the lung
tissue, the expression of both enzymes was also
increased in human fetal lung fibroblast (HFL-1) cul-
tures after treatment with curcumin. As shown in Figure
2A and 2B, CatK and L expression increased in the pre-
sence of curcumin in a dose-dependent manner after
treatment of the cells with bleomycin. Treatment with
30 μM of curcumin resulted in an about 100% increase
in the expression of CatK and L.
Effect of curcumin on collagen deposition in the lung and
on lung fibroblast proliferation and migration
Bleomycin-induced lung fibrosis is strongly associated
with extracellular matrix production and deposition.
When compared to untreated control mice, bleomycin-
treated animals showed an almost 100% increase in lung
collagen deposition 7 days after the initial bleomycin
instillation (Figure 3A and 3B). The collagen content
further increased to 113% at 28d. Oral application of
curcumin (200 mg/kg/d), beginning two days after the
bleomycin treatment, reduced the deposition of collagen
by 21% after 7d, 17% after 14d and 29% after 28d.
As fibroblasts represent the major cell type in lung
fibrotic tissue, we determined the effect of curcumin on
the proliferation and migration rates of HFL-1 cells.
HFL-1 cells were exposed to bleomycin (0.1 mU/ml)
and stimulated for 24, 48 and 72 h. Curcumin revealed
a dose-response related inhibition of cell proliferation
(Figure 3C) whereas bleomycin increased the prolifera-
tion rate by almost 100%. The anti-proliferative effect
became significant at curcumin concentrations equal or
higher than 10 μM. At 30 μM, the proliferation rates
were suppressed below the rate observed in the absence
of bleomycin.
Fibroblasts migration may accelerate fibroblast foci
formation and contribute to the development of lung
fibrosis. Thus, we determined the effect of curcumin on
transmigration rates of HFL-1 cells. As shown in Figure
3D, curcumin was effective in attenuating dose-depen-
dently fibroblast transmigration. Migration rates were
reduced up to 45% at 30 μM of curcumin.
Effect of curcumin on wound healing and its dependency
on cathepsin activities
Abnormal wound healing is a main contributor to lung
fibrosis. As shown in Figure 4A and 4B, curcumin
delayed wound healing in a dose-dependent manner.
Wound closure rates were reduced from 75% at 3 μM
curcumin to 17% at 30 μM of curcumin concentration.
Further, HFL-1 cells were incubated in the presence or
absence of 10 μM LHVS, a pan-cathepsin inhibitor, prior
to the wound making. After wound making, cells were
incubated with curcumin (30 μM) and bleomycin (0.1
mU/ml) with or without LHVS for 24 h and subsequently
allowed to grow in drug-free media (10% FBS in DMEM)
for another 48 h. As shown in Figure 4C, we found that
LHVS can significantly increase the rate of wound clo-
s u r e( p<0 . 0 5o rp<0 . 0 1 ) .T h e s er e s u l t si n d i c a t et h a t
curcumin can inhibit proliferation and migration in this
assay and that this partly depends on cathepsin activity.
Effect of curcumin on TGF-b1 expression and its
dependency on cathepsin activities
TGF-b1 plays a key role in the progression of lung
fibrosis and has been shown to be upregulated [25].
Inhibition of TGF-b1 attenuates exacerbation of lung
fibrosis [26]. First, we determined TGF-b1 expression in
bleomycin induced lung fibrosis in the absence or
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after bleomycin administration, the extent of TGF-b1
expression was decreased by 25% in the presence of cur-
c u m i nw h e nc o m p a r e dt ot h ea b s e n c eo fc u r c u m i na t
same time point. To reveal the influence of cathepsin
activity and their regulation by curcumin on TGF-b1
expression, we treated bleomycin stimulated HFL-1 cells
with curcumin. As shown in Figure 5B, TGF-b1e x p r e s -
sion was dose-dependently reduced by curcumin.
Further, TGF-b1 expression was increased two-fold by
the addition of the pan-cathepsin inhibitor, LHVS, in
t h ep r e s e n c eo fc u r c u m i n( 3 0μM) and bleomycin (0.1
mU/ml) (Figure 5C). To further elucidate cathepsin
expression in response to TGF-b1 stimulation typical in
bleomycin-induced lung fibrosis, we treated HFL-1 cells
w i t hac o n s t a n ta m o u n to fT G F - b1( 5n g / m l )a n dm e a -
sured the effect of curcumin on CatK and L expression.
The expressions of CatK and L were 2.5-fold lower in
the TGF-b1 only treated cells than in the control cells
(absence of TGF-b1 and curcumin) (Figure 5D). Addi-
tion of curcumin (20 μM) increased the expression of
CatK and L 7 and 5-fold, respectively.
Taken together, this may indicate that curcumin-
induced upregulation of cathepsins reduces the TGF-b1
content in fibroblasts and lung tissue.
Effect of curcumin on apoptosis and its dependency on
cathepsin activities
Apoptosis has been associated with both physiological
lung homeostasis and pathological lung remodeling [27].
Figure 1 Effect of curcumin on the expression of cathepsins K and L in mouse lungs of bleomycin induced fibrosis.R e p r e s e n t a t i v e
images (A) of immunohistochemical staining and quantification (B and C) of the expression of CatK and L in curcumin treated bleomycin
induced mice show that expressions of CatK and L were increased at 7d, 14 d and 28 d. Real time PCR results (D) also show RNA levels of CatK
were increased after curcumin and bleomycin treatment at the indicated time points. For each time point 9-10 mice were evaluated. All data
represent means ± SE (* p < 0.05, all compared to bleomycin treated group only; Con: control, BLM: bleomycin, Cur: curcumin).
Zhang et al. Respiratory Research 2011, 12:154
http://respiratory-research.com/content/12/1/154
Page 5 of 12Tissue sections of mouse lungs revealed a 33-41%
increase in Tunel positive (apoptotic) cells in curcumin
treated mice when compared to control bleomycin-trea-
ted littermates only (Figure 6A). This result suggests
that apoptosis might contribute to the regeneration of
fibrotic lung tissues. In order to investigate the effect of
cathepsin expression on promoting fibroblast apoptosis
as a response to curcumin administration, we deter-
mined the expression of caspase-3 and Bax/Bcl-2 in
bleomycin stimulated HFL-1 cells. Figures 6B and 6C
show that caspase-3 expression and the ratio of Bax/Bcl-
2 in HFL-1 cells were dose-dependently increased by 4.5
and 2.5-fold after 24 h of 30 μM curcumin treatment.
Subsequently, we examined whether the ability of cur-
cumin inducing cell apoptosis was cathepsin dependent,
LHVS was utilized to evaluate the alterations of caspase-
3, Bax, and Bcl-2 in bleomycin treated HFL-1 cells.
HFL-1 cells exposed to bleomycin were treated with 30
μM curcumin in the presence or absence of LHVS.
After 24 h, caspase-3 expression was investigated by
immunoblotting and immunofluorescence (data not
shown). Figure 6D reveals that LHVS significantly inhib-
ited caspase-3 expression (p < 0.05). Accordingly, the
ratio of Bax/Bcl-2 was reduced by LHVS as well (p <
0.05). These data indicate that curcumin is proapoptotic
and that the curcumin-dependent upregulation of cathe-
psins is directly contributing to increased apoptosis
rates.
Discussion
Curcumin has been extensively studied as a potential
drug for the treatment of lung fibrosis. Most of the
recent research indicates that the mechanism of block-
ing fibrosis by curcumin is related to decreasing col-
lagen accumulation in the lung [1] and to anti-oxidant
[2,28-30] and anti-inflammatory activities [24]. In vitro,
curcumin has the ability of inducing scleroderma fibro-
blast apoptosis [31], protecting rat lung epithelial cells
from quartz particle-mediated cytotoxic and inflamma-
tory effects [30], inhibiting lung fibroblast proliferation
[1], blocking the TGF-b1 signaling cascade [32], and
upregulating heme oxygenase-1 [33] in renal cells. No
data, however, have been reported to demonstrate a cur-
cumin-mediated effect on cathepsin expression in bleo-
mycin induced lung fibrosis as a pathway to control
extracellular matrix accumulation, cell proliferation, and
apoptosis. Here, we show that curcumin increases CatK
and L expression in vivo and in vitro and that the
observed effects on lung fibroblast cell proliferation,
m i g r a t i o na n da p o p t o s i sa sw e l la st h ee x p r e s s i o no f
TGF-b1 are linked to cysteine cathepsin activities. It
should be noted that we also observed an increase in
cathepsin B and S expression (albeit to a lesser degree
than cathepsins K and L) in lung tissues after curcumin
treatment (data not shown).
Bleomycin causes an increased expression of TGF-b1
in activated fibroblasts as shown in Figure 5. Increased
TGF-b1 levels promote ECM production and deposition
by inducing fibroblast differentiation into myofibroblasts
[34,35] and decreasing the expression of ECM degrading
proteases such as CatK in these cells [11]. CatK is a
highly potent collagenase and elastase and its downregu-
lation exerts a further increase in ECM accumulation in
fibrotic lungs as shown in CatK-deficient mice [8]. On
the other hand, it has been reported that CatK is
Figure 2 Overexpression of cathepsins K and L in curcumin
treated bleomycin stimulated human lung fibroblasts (HFL-1
cells). Representative images (A and B) of immunoblots and
measurements show that expressions of CatK and L were dose-
dependently increased by curcumin. All data represent means of
three independent experiments ± SD and represent percentage
cathepsin expression compared to b-actin as control (* p < 0.05, all
compared to bleomycin treated group only).
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fibrosis which has been interpreted as a countermeasure
to the increased ECM deposition [8,11]. In support of
these findings, CatK overexpressing transgenic mice
revealed a low degree of fibrosis in response to bleomy-
cin challenge when compared with wild type mice [10].
Here, we show that the antifibrotic activity of curcumin
is accompanied by about 2-fold increases in CatK and L
expression. An anti-fibrotic effect of cathepsin overex-
pression can have multiple causes. First, increased tissue
levels of proteases such as CatK will increase ECM
degradation. This is corroborated by our finding that
increased cathepsin expression is accompanied with a
decrease in collagen deposits in fibrotic lungs of bleo-
mycin-challenged mice and supported by several other
groups which reported a decrease in protein type I
collagen and hydroxyproline contents in curcumin trea-
ted fibrotic lungs of rats [1-3].
Second, increased cathepsin expression may directly
control TGF-b1 concentration in tissues by proteolysis.
We have recently demonstrated that CatK deficiency in
lung is associated with increased expression levels of
TGF-b1a n dt h a tC a t Ki sap o t e n tT G F - b1d e g r a d i n g
protease [9]. Here we show that a cathepsin inhibitor
increased TGF-b1 concentrations in fibroblasts by 100%
suggesting a direct regulation of TGF-b1 concentration
by cathepsin activities which will consequently affect
proliferation and migration rates of lung cells. It has
been demonstrated that abnormal repair and deregu-
lated wound healing partly result from abnormal fibro-
blast proliferation and migration [11,36] and is
stimulated by tissue factors such as collagen [37], PGDF
Figure 3 Effects of curcumin on collagen deposition in fibrotic lungs of mice (bleomycin-induced) and HFL-1 cell proliferation and
migration. Representative images of Masson trichrome staining (A) and quantitative image analysis (B) of collagen content in the lungs of 9-10
mice/group display a reduction of collagen by curcumin. MTT assay (C) shows curcumin dose-dependent decrease of proliferation of HFL-1 cells
in the presence of bleomycin (0.1 mU/ml) at 24, 48 and 72 h. Cell migration rates (D) of HFL-1 cells were also decreased by curcumin. All the
cell-related data represent means of three independent experiments ± SD. The Masson trichrome staining evaluation is based on the image
analysis of two tissue section per mouse and data represent means ± SE (* p < 0.05, all compared to bleomycin treated group only).
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and TGF-b1 by CatK may thus provide stimulation sig-
nals to slow down proliferation, migration, and wound
healing. Consequently, the administration of the cysteine
protease inhibitor, LHVS, significantly increased the
wound closure rate in a fibroblast scratch assay (Figure
4C) which was inhibited by the curcumin-mediated
overexpression of cathepsins.
Interestingly, the increase in cathepsin expression by
curcumin is greater under the condition of adding a
fixed amount of exogenous TGF-b1t ot h ec u l t u r e
media (Figure 5D) than in the presence of bleomycin
(Figure 2A and 2B) which has a TGF stimulatory effect.
TGF-b1 itself has a suppressing effect on cathepsin
expression (Figure 5D). This might be explained by the
curcumin-mediated expression of a potent TGF-b1
degrading cysteine protease such as CatK [9] which is
likely to deplete the amount of exogenously added TGF-
b1. In the case of bleomycin stimulation, TGF-b1 will
be continuously produced by the HFL-1 cells and thus
its anti-cathepsin expression effect remains stronger.
The third effect of increased cathepsin expression is
likely related to the apoptosis rates in fibrotic lungs.
Wound healing and balancing the deposition of extra-
cellular matrix largely depend on decreasing the resis-
tance of fibroblasts to apoptosis [41]. Inadequate
fibroblast and myofibroblast apoptosis may lead to the
formation of fibrotic lesions [42]. Here, we demon-
strated that curcumin increases apoptosis rates in
fibrotic lung tissues and HFL-1 cells. This was evi-
denced by the dose-dependent increase of apoptotic
markers such as of caspase-3 and the Bax/Bcl-2 ratio
(Figure 6) and is in line with the finding that curcumin
downregulates Bcl-2 in non-small cell lung cancer cells
[43]. There are several potential pathways which may
be responsible for curcumin induced fibroblast apopto-
sis. One pathway might be again related to TGF-b1.
High levels of TGF-b1 have been shown to promote
fibroblast resistance to apoptosis [44] whereas low
levels of TGF-b1 may sensitize fibroblast to apoptosis.
As discussed above the upregulation of cathepsin
expression by curcumin leads to an increased degrada-
tion of TGF-b1 and thus would increase apoptosis
rates. This is corroborated by the finding that curcu-
min increased the expression of caspase-3 and Bax/
Bcl-2 in our experiments. Furthermore, when LHVS
was employed as an antagonist to cysteine cathepsins
activities in curcumin treated and bleomycin stimu-
lated HFL-1 cells, the expression of proapoptotic mar-
kers was reduced. The cleavage of the Bcl-2 family
member Bid by cathepsins has been proposed as a pos-
sible mechanism of cathepsin-mediated apoptosis [45].
The in vivo efficacy results were obtained after oral
application of curcumin (200 mg/kg/d). Similar out-
comes in terms of collagen deposition and/or TGF
expression were observed by other authors using oral
applications of curcumin in rats [2,3,46], whereas a
recent study in mice reported efficacy only after i.p.
administration of curcumin [1]. We looked into changes
of ECM deposition based on Masson trichrome staining
and immunohistochemical analysis of cathepsin and
TGF-b1 expression whereas Smith and coworker [1]
studied the inflammatory cell content, airspace, and
hydroxyproline content. The hydroxyproline content as
a marker of collagen accumulation revealed a trend of
decrease by approximately 10% though not significant
after 21 days of treatment in the Smith study [1]. Our
data reflect a reduction in total collagen content by 18%
after 14d and 32% after 28d. It is likely that an i.p.
Figure 4 Effects of curcumin and a cathepsin inhibitor on
wound healing in HFL-1 cell scratch model. Representative
images of wound healing assay (A) and its quantification (B)
demonstrate the dose-dependent reduction of wound closure rates
by curcumin. In contrast, LHVS, a pan-cathepsin inhibitor
significantly increased wound closure rates (C). All data represent
means of three independent experiments ± SD (* p < 0.05, all
compared to bleomycin treated group only).
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Page 8 of 12Figure 5 Effects of curcumin on expressions of TGF-b1, and the effect of TGF-b1 on cathepsins K and L expression.R e p r e s e n t a t i v e
immunohistochemical images and image analysis (A) of TGF-b1 expression in bleomycin treated mice (9- 10 mice per group). Curcumin
significantly decreased TGF-b1 expressions at 14d and 28d. All data besides the TGF-b1 analysis (means ± SE) represent means of three
independent experiments ± SD (* p < 0.05, all compared to bleomycin treated group only). (B) Representative immunoblot images and their
quantitative analysis display the dose-dependent reduction of TGF-b1 protein content by curcumin in bleomycin treated HFL-1 cells. In contrast,
LHVS increased TGF-b1 protein content two-fold (C). Panel D shows a 7 and 5-fold increase in the expressions of CatK and L in TGF-b1 treated
HFL-1 cells when exposed to curcumin (20 μM) whereas TGF-b1 alone significantly decreased cathepsin expression. All data represent means of
three independent experiments ± SD (* p < 0.05, all compared to bleomycin or TGF-b1 treated group only).
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Page 9 of 12administration of curcumin would have resulted to more
dramatic differences in our experiment as well.
In summary, our data provide evidence that cathepsin
expression is increased in response to curcumin treat-
ment in bleomycin challenged mice and HFL-1 cells.
The elevated levels of cathepsins may directly promote
ECM degradation, apoptosis and a decrease in TGF-b1
expression which indirectly affects fibroblast prolifera-
tion and thus ECM production, cell migration and apop-
tosis. This study adds to the increasing evidence that
curcumin may represent a potentially effective drug for
the treatment of human lung fibrosis.
Figure 6 Effects of curcumin and a cathepsin inhibitor on the expression of apoptosis markers in bleomycin stimulated HFL-1 cells.
Quantitative analysis of Tunel-positive staining in lungs of curcumin treated bleomycin-induced lung injury (A). Representative immunoblot
images and their quantitative analysis (B and C) show that curcumin increases caspase-3, Bax/Bcl-2 expression in a dose-dependent manner.
LHVS, a pan-cathepsin inhibitor is able to reverse the proapoptotic effect of curcumin as seen by the reduction of caspase-3 expression and the
Bax/Bcl-2 ratio in HFL-1 cells (D). All data represent means of three independent experiments ± SD. (* p < 0.05, all compared to bleomycin
treated group only).
Zhang et al. Respiratory Research 2011, 12:154
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